This inventor holds 1 USPTO granted patent. Top assignee: Ajinomoto Co., Ltd.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Masahiro Yamanashi: Innovator in Anticoagulant Research
Introduction
Masahiro Yamanashi is a prominent inventor based in Kawasaki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anticoagulants. His innovative work has led to the creation of compounds that have the potential to improve blood coagulation therapies.
Latest Patents
Yamanashi holds a patent for benzamidine derivatives, which are compounds that exhibit a blood-coagulation inhibiting effect. These derivatives are characterized by their ability to inhibit the action of activated blood coagulation factor X. This property makes them valuable as anticoagulants, providing a new avenue for therapeutic applications in managing blood coagulation disorders. He has 1 patent to his name.
Career Highlights
Yamanashi is associated with Ajinomoto Co., Ltd., a leading company in the food and pharmaceutical industries. His work at Ajinomoto has allowed him to focus on research and development in the area of anticoagulants, contributing to advancements in medical treatments.
Collaborations
Throughout his career, Yamanashi has collaborated with notable colleagues, including Masaru Takayanagi and Kazuyuki Sagi. These collaborations have fostered a productive research environment, leading to innovative solutions in the pharmaceutical sector.
Conclusion
Masahiro Yamanashi's contributions to anticoagulant research exemplify the impact of innovation in the pharmaceutical industry. His work continues to pave the way for advancements in medical therapies that can benefit patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
